133 related articles for article (PubMed ID: 17525628)
1. Metallothionein immunolocalization in actinic skin nonmelanoma carcinomas.
Borges Júnior PC; Ribeiro RI; Cardoso SV; Berbet AL; Rocha A; Espindola FS; Loyola AM
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):165-9. PubMed ID: 17525628
[TBL] [Abstract][Full Text] [Related]
2. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
[TBL] [Abstract][Full Text] [Related]
3. Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
de Oliveira Poswar F; de Carvalho Fraga CA; Gomes ES; Farias LC; Souza LW; Santos SH; Gomez RS; de-Paula AM; Guimarães AL
Int J Surg Pathol; 2015 Feb; 23(1):20-5. PubMed ID: 24984957
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
[TBL] [Abstract][Full Text] [Related]
5. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
6. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.
Abdou AG; Eldien MM; Elsakka D
Int J Surg Pathol; 2015 Sep; 23(6):447-53. PubMed ID: 26092229
[TBL] [Abstract][Full Text] [Related]
7. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
Zhang X; Egawa K; Xie Y; Ihn H
Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas.
Abdou AG; Maraee AH; El-Sayed EM; Elnaidany NF
Ann Diagn Pathol; 2011 Dec; 15(6):394-401. PubMed ID: 21849257
[TBL] [Abstract][Full Text] [Related]
9. Expression of metallothioneins in cutaneous squamous cell carcinoma and actinic keratosis.
Zamirska A; Matusiak Ł; Dziegiel P; Szybejko-Machaj G; Szepietowski JC
Pathol Oncol Res; 2012 Oct; 18(4):849-55. PubMed ID: 22407324
[TBL] [Abstract][Full Text] [Related]
10. Metallothionein 3 expression in normal skin and malignant skin lesions.
Pula B; Tazbierski T; Zamirska A; Werynska B; Bieniek A; Szepietowski J; Rys J; Dziegiel P; Podhorska-Okolow M
Pathol Oncol Res; 2015 Jan; 21(1):187-93. PubMed ID: 25015776
[TBL] [Abstract][Full Text] [Related]
11. Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin.
Stelkovics E; Kiszner G; Meggyeshazi N; Korom I; Varga E; Nemeth I; Molnar J; Marczinovits I; Krenacs T
Histol Histopathol; 2013 Jul; 28(7):941-54. PubMed ID: 23446646
[TBL] [Abstract][Full Text] [Related]
12. ACE and ACE2 expression in normal and malignant skin lesions.
Grzegrzolka J; Swiatko K; Pula B; Zamirska A; Olbromski M; Bieniek A; Szepietowski J; Rys J; Dziegiel P; Podhorska-Okolow M
Folia Histochem Cytobiol; 2013; 51(3):232-8. PubMed ID: 24203630
[TBL] [Abstract][Full Text] [Related]
13. Expression of metallothionein I/II and Ki-67 antigen in various histological types of basal cell carcinoma.
Bieniek A; Pula B; Piotrowska A; Podhorska-Okolow M; Salwa A; Koziol M; Dziegiel P
Folia Histochem Cytobiol; 2012 Oct; 50(3):352-7. PubMed ID: 23042264
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of cytokeratin 15, cytokeratin 19, follistatin, and Bmi-1 in basal cell carcinoma.
Kim HC; Sohng SH; Shin DH; Choi JS; Bae YK
Int J Dermatol; 2016 Jan; 55(1):36-44. PubMed ID: 26739632
[TBL] [Abstract][Full Text] [Related]
15. Greater expression of TC21/R-ras2 in highly aggressive malignant skin cancer.
Lee JH; Pyon JK; Lee SH; Lee YJ; Kang SG; Kim CH; Kim DW; Nam HS; Park YH; Jeong DJ; Cho MK
Int J Dermatol; 2011 Aug; 50(8):956-60. PubMed ID: 21781067
[TBL] [Abstract][Full Text] [Related]
16. Expression of RPE65, a putative receptor for plasma retinol-binding protein, in nonmelanocytic skin tumours.
Hinterhuber G; Cauza K; Dingelmaier-Hovorka R; Diem E; Horvat R; Wolff K; Foedinger D
Br J Dermatol; 2005 Oct; 153(4):785-9. PubMed ID: 16181461
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of glioma-associated oncogene homolog 1 in non melanoma skin cancer.
Bakry OA; Samaka RM; Shoeib MA; Megahed DM
Ultrastruct Pathol; 2015 Apr; 39(2):135-46. PubMed ID: 25350271
[TBL] [Abstract][Full Text] [Related]
18. Histopathological study of perilesional skin in patients diagnosed with nonmelanoma skin cancer.
Apalla Z; Calzavara-Pinton P; Lallas A; Argenziano G; Kyrgidis A; Crotti S; Facchetti F; Monari P; Gualdi G
Clin Exp Dermatol; 2016 Jan; 41(1):21-5. PubMed ID: 26189480
[TBL] [Abstract][Full Text] [Related]
19. Differential immunohistochemical expression of matrix metalloproteinase-10 (MMP-10) in non-melanoma skin cancers of the head and neck.
Kadeh H; Saravani S; Heydari F; Shahraki S
Pathol Res Pract; 2016 Oct; 212(10):867-871. PubMed ID: 27567711
[TBL] [Abstract][Full Text] [Related]
20. Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer.
Mancuso M; Gallo D; Leonardi S; Pierdomenico M; Pasquali E; De Stefano I; Rebessi S; Tanori M; Scambia G; Di Majo V; Covelli V; Pazzaglia S; Saran A
Carcinogenesis; 2009 Feb; 30(2):340-7. PubMed ID: 18952596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
